5 Nov 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
4 Nov 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
5 Aug 2025 Date | | - Cons. EPS | - EPS |
5 Nov 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
4 Nov 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
5 Aug 2025 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Jon R. Levine CEO | CNSX Exchange | - ISIN |
US Country | 643 Employees | - Last Dividend | - Last Split | - IPO Date |
MariMed Inc. is a distinguished entity in the cannabis industry, focusing on the cultivation, production, and dispensing of both medicinal and recreational cannabis across the United States and internationally. With its incorporation in 2011 and headquarters in Norwood, Massachusetts, MariMed has carved a niche for itself by offering a wide range of high-quality cannabis products under several well-recognized brands. The company operates with a commitment to excellence and innovation in the cannabis space, ensuring that it meets the diverse needs of its customers through exceptional product offerings and services.